The immune function differences and high-risk human papillomavirus infection in the progress of cervical cancer

被引:0
作者
Li, Changdong [1 ]
Ma, Cui [2 ]
Zhang, Weiyuan [2 ]
Wang, Jiandong [2 ]
机构
[1] Dept Gynecol & Family Planning, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Gynecol Oncol, Beijing 100026, Peoples R China
关键词
Cervical cancer; Cervical intraepithelial neoplasia; Immune function; High-risk HPV; T-CELLS; DENDRITIC CELLS; RESPONSES; CARCINOMA; VACCINES; DNA;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Investigation: To study the differences immune function in normal cervix, cervical intraepithelial neoplasia (CIN) and cervical cancer tissue, and study the relationship between human papillomavirus (ITV) infection and cervical local immune function. Materials and Methods: This study determined the form, quantity, distribution, and intensity of CD4(+)Th cells, S-100(+) dendritic cells (DCs) and CD57(+)NK cells in the normal cervical tissue, CIN cervical tissue, and cervical cancer by histopathological and image analyses. Results: The immune function was differences in the progress of cancer genesis. The numbers of the CD4(+) Th cells, S-100(+) DCs, and CD57(+)NK cells increased with the progress of the disease in CIN, but when cancer occurred, immune cells decreased in local cervical tissue. Conclusion: From lesion precancerous to infiltrating carcinoma, the form, quantity, and intensity of expression of immune cells changed, which may indicate that the cervical local immune function has changed. Furthermore, high-risk HPV infections are more active in local immune function.
引用
收藏
页码:557 / 561
页数:5
相关论文
共 22 条
[11]   Maintenance of CD8 effector T cells by CD4 helper T cells eradicates growing tumors and promotes long-term tumor immunity [J].
Lin, Cheng-Tao ;
Chang, Ting-Chang ;
Shaw, Sheng-Wen ;
Cheng, Po-Jen ;
Huang, Ching-Tai ;
Chao, Angel ;
Soong, Yung-Kuei ;
Lai, Chyong-Huey .
VACCINE, 2006, 24 (37-39) :6199-6207
[12]   The role of suppressor T cells in regulation of immune responses [J].
McHugh, RS ;
Shevach, EM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (05) :693-702
[13]  
Pardo-Govea Tatiana, 2005, Invest. clín, V46, P5
[14]   Host immune responses to cervical cancer [J].
Patel, Swati ;
Chiplunkar, Shubhada .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2009, 21 (01) :54-59
[15]   Stromal issues in cervical cancer: a review of the role and function of basement membrane, stroma, immune response and angiogenesis in cervical cancer development [J].
Sahebali, Shaira ;
Van den Eynden, Gert ;
Murta, Eddie F. ;
Michelin, Marcia A. ;
Cusumano, Pino ;
Petignat, Patrick ;
Bogers, Johannes J. .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2010, 19 (03) :204-215
[16]   Overview of cervical cancer in the developing world [J].
Sankaranarayanan, R. .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2006, 95 :S205-S210
[17]   Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR plus T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix [J].
Santin, AD ;
Ravaggi, A ;
Bellone, S ;
Pecorelli, S ;
Cannon, M ;
Parham, GP ;
Hermonat, PL .
GYNECOLOGIC ONCOLOGY, 2001, 81 (03) :424-432
[18]   Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer [J].
Sasagawa, Toshiyuki ;
Takagi, Hiroaki ;
Makinoda, Satoru .
JOURNAL OF INFECTION AND CHEMOTHERAPY, 2012, 18 (06) :807-815
[19]   Common Variants in Immune and DNA Repair Genes and Risk for Human Papillomavirus Persistence and Progression to Cervical Cancer [J].
Wang, Sophia S. ;
Concepcion Bratti, M. ;
Rodriguez, Ana Cecilia ;
Herrero, Rolando ;
Burk, Robert D. ;
Porras, Carolina ;
Gonzalez, Paula ;
Sherman, Mark E. ;
Wacholder, Sholom ;
Lan, Z. Elizabeth ;
Schiffman, Mark ;
Chanock, Stephen J. ;
Hildesheim, Allan .
JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (01) :20-30
[20]   Disease-stage variance in functional CD4+ T-cell responses against novel pan-human leukocyte antigen-D region presented human papillomavirus-16 E7 epitopes [J].
Warrino, DE ;
Olson, WC ;
Knapp, WT ;
Scarrow, MI ;
D'Ambrosio-Brennan, LJ ;
Guido, RS ;
Edwards, RP ;
Kast, WM ;
Storkus, WJ .
CLINICAL CANCER RESEARCH, 2004, 10 (10) :3301-3308